Postpartum depression

Article

Because new mothers see pediatricians after giving birth more often than they see their obstetricians, it's only natural that they are in a better position to screen and observe possible cases of postpartum depression.

Key Points

Postpartum depression (PPD) is the most common and serious postpartum condition, affecting 10% to 20% of mothers within the first year of childbirth.1 Studies have found that up to 50% of women with PPD go undiagnosed.2 Risk factors comprise a prior history of depression, including PPD, and depression during pregnancy. The World Health Organization has identified major depression as the fourth-leading cause of disease, with estimated costs of $30 billion to $50 billion in lost productivity and medical costs in the United States per year.1 Women with a prior history of postpartum depression have an approximate 25% to 50% risk of recurrence.3,4 Other risk factors include recent stressful life events, lack of social support, and unintended pregnancy.5

Postpartum depression has been shown to be more common among women who are economically stressed or disadvantaged and is highly prevalent in low-income, black mothers.2 Studies of economically disadvantaged families have shown that depressive symptoms can last beyond the initial postpartum year, which exceeds the current diagnostic criteria for PPD, and have a prevalence of 23% to 25%.6

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.